Rellum Santino R, Kho Eline, Schenk Jimmy, van der Ster Björn J P, Vlaar Alexander P J, Veelo Denise P
From the Department of Anaesthesiology (SRR, EK, JS, BJPvdS, DPV), Department of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences (SRR, EK, JS, APJV) and Department of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health, Amsterdam, the Netherlands (JS).
Eur J Anaesthesiol. 2025 Feb 1;42(2):131-139. doi: 10.1097/EJA.0000000000002082. Epub 2024 Oct 16.
Clinical trials and validation studies demonstrate promising hypotension prediction capability by the Hypotension Prediction Index (HPI). Most studies that evaluate HPI derive it from invasive blood pressure readings, but a direct comparison with the noninvasive alternative remains undetermined. Such a comparison could provide valuable insights for clinicians in deciding between invasive and noninvasive monitoring strategies.
Evaluating predictive differences between HPI when obtained through noninvasive versus invasive blood pressure monitoring.
Post hoc analysis of a prospective observational study conducted between 2018 and 2020.
Single-centre study conducted in an academic hospital in the Netherlands.
Adult noncardiac surgery patients scheduled for over 2 h long elective procedures. After obtaining informed consent, 91 out of the 105 patients had sufficient data for analysis.
The primary outcome was the difference in area under the receiver-operating characteristics (ROC) curve (AUC) obtained for HPI predictions between the two datasets. Additionally, difference in time-to-event estimations were calculated.
AUC (95% confidence interval (CI)) results revealed a nonsignificant difference between invasive and noninvasive HPI, with areas of 94.2% (90.5 to 96.8) and 95.3% (90.4 to 98.2), respectively with an estimated difference of 1.1 (-3.9 to 6.1)%; P = 0.673. However, noninvasive HPI demonstrated significantly longer time-to-event estimations for higher HPI values.
Noninvasive HPI is reliably accessible to clinicians during noncardiac surgery, showing comparable accuracy in HPI probabilities and the potential for additional response time.
Clinicaltrials.gov (NCT03795831) https://clinicaltrials.gov/study/NCT03795831.
临床试验和验证研究表明,低血压预测指数(HPI)具有良好的低血压预测能力。大多数评估HPI的研究是从有创血压读数中得出该指数的,但与无创血压读数的直接比较仍未确定。这样的比较可为临床医生在有创和无创监测策略之间做出决策提供有价值的见解。
评估通过无创与有创血压监测获得的HPI之间的预测差异。
对2018年至2020年进行的一项前瞻性观察性研究进行事后分析。
在荷兰一家学术医院进行的单中心研究。
计划进行超过2小时长的择期手术的成年非心脏手术患者。在获得知情同意后,105名患者中的91名有足够的数据用于分析。
主要结局是两个数据集中HPI预测的受试者操作特征(ROC)曲线下面积(AUC)的差异。此外,还计算了事件发生时间估计值的差异。
AUC(95%置信区间(CI))结果显示,有创和无创HPI之间无显著差异,面积分别为94.2%(90.5至96.8)和95.3%(90.4至98.2),估计差异为1.1%(-3.9至6.1);P = 0.673。然而,对于较高的HPI值,无创HPI显示出明显更长的事件发生时间估计值。
在非心脏手术期间,临床医生可可靠地获取无创HPI,其在HPI概率方面显示出可比的准确性,并具有额外反应时间的潜力。
Clinicaltrials.gov(NCT03795831)https://clinicaltrials.gov/study/NCT03795831 。